Cargando…
The Changing Face of Spondyloarthropathies Under TNF α Blockade
OBJECTIVES: Tumor necrosis factor alpha (TNF-α ) therapy has been implicated in the development of autoimmune diseases. Our aim was to describe three patients with spondyloarthropathies who responded to infliximab, a chimeric monoclonal antibody specific for TNF-α but developed new symptoms of spond...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Open
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588090/ https://www.ncbi.nlm.nih.gov/pubmed/19088872 http://dx.doi.org/10.2174/1874312900802010053 |